Is the Laron mouse an accurate model of Laron syndrome?

Molecular Genetics and Metabolism

Volumn 68, Issue 2, 1999, Pages 232-236

  Kopchick, John J ^a   Laron, Zvi ^b  

^a OHIO UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GONADOTROPIN; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; GROWTH HORMONE RELEASING FACTOR; LUTEINIZING HORMONE; PROLACTIN; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BONE MATURATION; CONTROLLED STUDY; DELAYED PUBERTY; GENE DELETION; GENE MUTATION; GLUCOSE METABOLISM; HORMONE RESISTANCE; LARON SYNDROME; LIFESPAN; MALE FERTILITY; MISSENSE MUTATION; MOUSE; NONHUMAN; NONSENSE MUTATION; POINT MUTATION; PRIORITY JOURNAL; SEXUAL DEVELOPMENT; SHORT SURVEY; WEIGHT GAIN;

ANIMALIA;

EID: 0032731982     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2890     Document Type: Article

References (33)

1. Laron Z, Blum W, Chatelain P, Ranke M, Rosenfeld R, Savage M, Underwood L. Classification of growth hormone insensitivity syndrome [editorial]. J Pediatr. 122:1993;241.
2. Laron Z. Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient. J Clin Endocrinol Metab. 80:1995;1526-1531.
3. Eshet R, Laron Z, Pertzelan A, Arnon R, Dintzman M. Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism. Isr J Med Sci. 20:1984;8-11.
4. Godowski P J, Leung D W, Meacham L R, Galgani J P, Hellmiss R, Keret R, Rotwein P S, Parks J S, Laron Z, Wood W I. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA. 86:1989;8083-8087.
5. Berg M A, Argente J, Chernausek S, Gracia R, Guevara-Aguirre J, Hopp M, Perez-Jurado L, Rosenbloom A, Toledo S P, Francke U. Diverse growth hormone receptor gene mutations in Laron syndrome. Am J Hum Genet. 52:1993;998-1005.
6. Amselem S, Goossens M. Hereditary dwarfism. Presse Med. 19:1990;1699-1701.
7. Kou K, Lajara R, Rotwein P. Amino acid substitutions in the intracellular part of the growth hormone receptor in a patient with the Laron syndrome. J Clin Endocrinol Metab. 76:1993;54-59.
8. Duquesnoy P, Sobrier M L, Duriez B, Dastot F, Buchanan C R, Savage M O, Preece M A, Craescu C T, Blouquit Y, Goossens M. A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization. EMBO J. 13:1994;1386-1395.
9. Goddard A D, Covello R, Luoh S M, Clackson T, Attie K M, Gesundheit N, Rundle A C, Wells J A, Carlsson L M. Mutations of the growth hormone receptor in children with idiopathic short stature. N Engl J Med. 333:1995;1093-1098.
10. Woods K A, Fraser N C, Postel-Vinay M C, Savage M O, Clark A J. A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein [see comments]. J Clin Endocrinol Metab. 81:1996;1686-1690.
11. Ayling R M, Ross R, Towner P, Von Laue S, Finidori J, Moutoussamy S, Buchanan C R, Clayton P E, Norman M R. A dominant-negative mutation of the growth hormone receptor causes familial short stature [letter]. Nature Genet. 16:1997;13-14.
12. Laron Z. Laron syndrome - Primary growth hormone resistance. Jameson J L. Hormone Resistance Syndromes, Contemporary Endocrinology. 1999;17-37 Humana Press, Totowa.
13. Baumann G, Shaw M A, Winter R J. Absence of the plasma growth hormone-binding protein in Laron-type dwarfism. J Clin Endocrinol Metab. 65:1987;814-816.
14. Daughaday W H, Trivedi B. Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism). Proc Natl Acad Sci USA. 84:1987;4636-4640.
15. Laron Z, Klinger B, Erster B, Silbergeld A. Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism. Acta Endocrinol (Copenh). 121:1989;603-608.
16. Amselem S, Duquesnoy P, Duriez B, Dastot F, Sobrier M L, Valleix S, Goossens M. Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome. Hum Mol Genet. 2:1993;355-359.
17. Rosenbloom A L, Guevara Aguirre J, Rosenfeld R G, Fielder P J. The little women of Loja - Growth hormone-receptor deficiency in an inbred population of southern Ecuador. N Engl J Med. 323:1990;1367-1374.
18. Silbergeld A, Dastot F, Klinger B, Kanety H, Eshet R, Amselem S, Laron Z. Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: Extended phenotypic study in a very large pedigree. J Pediatr Endocrinol Metab. 10:1997;265-274.
19. Laron Z, Klinger B, Eshet R, Kaneti H, Karasik A, Silbergeld A. Laron syndrome due to a post-receptor defect: Response to IGF-I treatment. Isr J Med Sci. 29:1993;757-763.
20. Zhou Y, Xu B C, Maheshwari H G, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamo K, Wagner T E, Baumann G, Kopchick J J. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA. 94:1997;13215-13220.
21. Silbergeld A, Keret R, Selman-Almonte A, Klinger B, Laron Z. Serum growth hormone binding protein in Laron syndrome patients and their relatives. Laron Z, Parks J S. Lessons from Laron Syndrome (LS) 1966-1992 - A Model of GH and IGF-I Action and Interaction, Pediatric and Adolescent Endocrinology. 1993;153-159 Karger, Basel.
22. Laron Z, Klinger B, Grunebaum M, Feingold M, Tunnessen W W. Picture of the month. Am J Dis Child. 145:1991;473-474.
23. Laron Z, Klinger B. Body fat in Laron syndrome patients: Effect of insulin-like growth factor I treatment. Horm Res. 40:1993;16-22.
24. Laron Z, Pertzelan A, Karp M. Laron syndrome - A unique model of IGF-I deficiency. Laron Z, Parks J S. Lessons from Laron Syndrome (LS) 1966-1992 - A Model of GH and IGF-I Action and Interaction, Pediatric and Adolescent Endocrinology. 1993;3-23 Karger, Basel.
25. Laron Z, Avitur Y, Klinger B. Insulin resistance in Laron syndrome (primary insulin-growth factor-I [IGF-I] deficiency) and effect of IGF-I replacement therapy. J Pediatr Endocrinol Metab. 10:1997;105-115.
26. Laron Z, Karp M. Carbohydrate metabolism in the syndrome of familial dwarfism and high plasma immunoreactive growth hormone (Laron type dwarfism). Podolsky S, Wiswanathan M. Secondary Diabetes: The Spectrum of the Diabetic Syndrome. 1980;363-371 Raven Press, New York.
27. Laron, Z, Short stature due to abnormalities in GH receptor and post-receptor defects - Laron syndrome; GH resistance/insensitivity. In, Endocrinologia Pediatrica y de la Adolescencia, 2 ed. (, Argente, J, Carrascosa, A, Gracia, R, Rodriguez, F, Eds.), Madrid, Ediciones DOYMA.SA, in press.
28. Danilovich, N, Wernsing, D, Coschigano, K, T, Kopchick, J, J, Bartke, A, Deficits in female reproductive function in GH-R-KO mice; role of IGF-I, Endocrinology, in press.
29. Chandrashekar V, Bartke A, Coschigano K T, Kopchick J J. Pituitary and testicular function in growth hormone receptor gene knockout mice. Endocrinology. 140:1999;1082-1088.
30. Laron Z, Sarel R. Penis and testicular size in patients with growth hormone insufficiency. Acta Endocrinol (Copenh). 63:1970;625-633.
31. Laron Z, Sarel R, Pertzelan A. Puberty in Laron type dwarfism. Eur J Pediatr. 134:1980;79-83.
32. Silbergeld A, Klinger B, Schwartz H, Laron Z. Serum prolactin in patients with Laron-type dwarfism: Effect of insulin-like growth factor I. Horm Res. 37:1992;160-164.
33. Laron Z, Pertzelan A, Karp M. Pituitary dwarfism with high serum levels of growth hormone. Isr J Med Sci. 4:1968;883-894.